Michael J. Kemeter | MedReviews

Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score
Reviews in Urology
Volume 18, No 3 - 2016
Active Surveillance Use Among a Low-risk Prostate Cancer Population in a Large US Payer System: 17-Gene Genomic Prostate Score Versus Other Risk Stratification Methods
Original Research
Reviews in Urology
Volume 19, Number 4 - 2017